Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1998;97:2073-2078

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schauerte, P.
Right arrow Articles by Stellbrink, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schauerte, P.
Right arrow Articles by Stellbrink, C.

(Circulation. 1998;97:2073-2078.)
© 1998 American Heart Association, Inc.


Basic Science Reports

Influence of Phase Duration of Biphasic Waveforms on Defibrillation Energy Requirements With a 70-µF Capacitance

Patrick Schauerte, MD; Friedrich A. Schöndube, MD; Marius Grossmann, MD; Hilmar Dörge, MD; Frank Stein, BSE; Bernd Dohmen, BSE; Abdel Moumen, MD; Konstantin Erena, MD; Bruno J. Messmer, MD; Peter Hanrath, MD; ; Christoph Stellbrink, MD

From the Department of Cardiology (P.S., F.S., B.D., A.M., K.E., P.H., C.S.) and the Department of Thoracic and Cardiovascular Surgery (F.A.S., M.G., H.D., B.J.M.), University Hospital-RWTH Aachen (Germany).

Correspondence to Patrick Schauerte, MD, Department of Cardiology, University Hospital-RWTH Aachen, Pauwelsstraße 30, 52057 Aachen, FRG. E-mail psch{at}pcserver.mk1.rwth-aachen.de


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background—Phase duration of biphasic shocks may be an important determinant of defibrillation success. The purpose of this study was to investigate the effect of changing phase duration of biphasic pulses delivered by 70-µF capacitors on defibrillation energy requirements. This may be clinically relevant for the optimization of implantable cardioverter-defibrillator design and programming.

Methods and Results—Defibrillation thresholds (DFTs) were determined for 13 waveforms in 13 pigs by application of a 70-µF capacitance and a transvenous/submuscular lead system. In part I, phase-1 duration varied, preserving a phase-1/phase-2 duration ratio of 60%/40%. The phase-1 durations were 1, 2, 3, 4, 5, and 6 ms. The DFT was lowest (22.9±7 J) for phase 1=3 ms compared with phase 1=1 ms (36.4±7.5 J), 2 ms (25±6.5 J), 4 ms (25±7.6 J), 5 ms (30.7±7.3 J), or 6 ms (32.9±8.1 J) (P<.001). In part II, phase-1 duration was 3 ms but phase-2 duration varied: 0.7, 1.3, 2, 2.7, 3.3, 4, and 6 ms. Significant DFT minima were found at phase 2=2 ms (22.5±4.2 J) and phase 2=4 ms (22.5±4.2 J) compared with phase 2=0.7 ms (31.7±9.3 J), phase 2=3.3 ms (26.7±6.1 J), or phase 2=6 ms (28.3±6.8 J) (P<.05).

Conclusions—The strength-duration curve of biphasic defibrillation shocks demonstrates a single optimum for phase-1 duration. In contrast, two optima with minimal energy requirements were found for phase-2 duration. Optimization of both phases of low-capacitance biphasic shocks may reduce energy requirements for defibrillation.


Key Words: fibrillation • defibrillation • death, sudden


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Current implantable cardioverter/defibrillators (ICDs) incorporate a 120- to 150-µF capacitor, which accounts for about one third of the total device volume.1 Because ICD volumes may be reduced by incorporation of smaller capacitors, several animal and clinical studies compared ICDs with capacitors of 120 to 140 µF with those with lower capacitors of 60 to 85 µF and revealed an at least equal defibrillation efficacy in terms of stored energy.2 3 4 5 However, smaller capacitors must be loaded to a higher voltage for storing the same energy according to the capacitor formula E=1/2xCxU2, where E is energy, C is capacitance, and U is voltage. By retaining present maximal ICD voltage outputs, this may decrease the safety margin for defibrillation, assuming an equal defibrillation threshold (DFT) in terms of stored energy. Furthermore, because the capacitor volume is proportional to the maximum capacitor energy, a reduction of the capacitor volume by smaller capacitances is only possible if defibrillation energy requirements are lowered.3 The phase duration of defibrillation shocks is an important factor influencing the DFT.6 7 Because the time constant {tau} (time that is required to deliver 68% of the stored energy) is directly related to the capacitor following the equation {tau}=RxC (R=resistance), shocks delivered from smaller capacitors need less time to deliver the same amount of energy than shocks from larger capacitors. We hypothesized that DFTs for 70-µF capacitors may have a minimum at other pulse widths and tilts than for larger capacitors and investigated the relation between phase duration of biphasic shocks and the defibrillation energy requirement for 70-µF capacitors.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Animal Preparation
All studies followed institutional guidelines for animal trials and were undertaken with permission of the competent authorities (Regierungspräsident Köln, April 14, 1992). We studied 13 healthy domestic pigs (German landrace) weighing 70±6 kg. Ketamine (20 mg/kg body wt IM) and atropine (0.14 mg/kg body wt IM) were used to induce anesthesia. The animals were intubated with a cuffed endotracheal tube and ventilated with NO2/O2 (ratio 3:1) by a ventilator (Servo Respirator, Siemens Corp) at 10 to 15 breaths/min. Sodium pentobarbital (1 to 2 mg/kg) was infused to maintain a constant depth of anesthesia. Systemic blood pressure was continuously monitored through a carotid arterial line and blood gas analysis performed every 30 minutes. Metabolic status was further monitored by taking central venous blood samples for electrolytes every 30 minutes. Pulmonary capillary wedge pressure and mixed venous oxygenation were continuously measured by a Swan-Ganz-catheter. Surface ECG was recorded during each fibrillation/defibrillation episode on a 12-channel standard ECG recorder (Mingograph, Siemens) at a paper speed of 25 mm/s. After left jugular venotomy, a transvenous defibrillation electrode (Endotak 072, CPI) was introduced under fluoroscopy in the right ventricular apex. The electrode carries two coils, one positioned in the right ventricular apex (distal coil) and one in the superior vena cava (proximal coil). A submuscular patch (Endotak Sub Q 042, CPI) was then placed at the left thoracic wall opposite to the left ventricle. The electrodes were connected with the distal coil in the right ventricular apex as anode and with the proximal coil and submuscular patch as common cathode during phase-1 of the biphasic shocks. Shocks were delivered by a 70-µF capacitor (model 2394, Medtronic) that allowed separate selection of pulse width, voltage, and intershock delay. Shock voltage values of the leading edge of phase 1 to be charged on the capacitors were calculated according to the equation E=1/2xCxU2. Voltage and current at the leading and trailing edge of phase 1 were recorded on an oscilloscope. Leading edge voltage of phase 2 was adjusted to the same value as the voltage at the trailing edge of phase 1. To estimate the voltage at the trailing edge of phase 1, monophasic shocks of all different phase-1 durations were delivered to each pig heart at each energy level. The leading edge voltage of phase 2 of the biphasic shock was then adjusted to the voltage at the end of the respective monophasic shocks.

Defibrillation Protocol
Part I
In the first part of the study, six different phase-1 durations were tested in 7 pigs. A constant phase-1/phase-2 duration ratio of 60%/40% was used. The corresponding phase-1 tilt was calculated by (1-U2/U1)x100 (%) (U1=voltage at the leading edge of phase 1; U2=voltage at the trailing edge of phase 1). Interpulse delay was kept constant at 0.8 ms. The total shock durations tested were 10.8 ms (phase 1: 6 ms/phase-2: 4 ms/phase-1 tilt: 83%), 9.1 ms (5 ms/3.3 ms/78%), 7.5 ms (4 ms/2.7 ms/68%), 5.8 ms (3 ms/2 ms/60%), 4.1 ms (2 ms/1.3 ms/48%), and 2.5 ms (1 ms/0.7 ms/33%) (Fig 1Down top).



View larger version (22K):
[in this window]
[in a new window]
 
Figure 1. Waveform modifications applied. Top, Waveforms during part I of the study. Six different phase-1 durations of biphasic shocks are depicted. For each waveform the ratio of phase-1 duration/phase-2 duration was 60%/40% and the intershock delay 0.8 ms. Bottom, Waveforms during part II of the study. Seven different waveforms were tested, each of which had a constant phase-1 duration of 3 ms but a varying phase-2 duration as indicated.

Part II
In the second part of the study, phase-1 duration was kept constant at 3 ms, which had turned out to be the optimal phase-1 duration in the first part of the study. Phase-2 duration was then systematically varied in another 6 pigs, resulting in different phase-1/phase-2 ratios. The tested durations for phase 2 were 0.7 ms (phase-1 duration/phase-2 duration ratio: 80%/20%), 1.3 ms (75%/25%), 2 ms (60%/40%), 2.7 ms (53%/47%), 3.3 ms (48%/52%), 4 ms (43%/57%), and 6 ms (33%/67%) (Fig 1Up bottom).

DFT testing was completely randomized, that is, each shock had a randomly assigned energy level and duration. Each waveform was tested five times at each energy level from 5 to 40 J in 5-J steps. Therefore, in each pig, 240 episodes of ventricular fibrillation were induced during part I and 280 episodes of ventricular fibrillation in part II. The DFT of a waveform was defined as the lowest energy level with at least 80% defibrillation success (ie, four or five of five delivered shocks were successful). Fibrillation was induced through the right ventricular pacing leads with a burst of 50 Hz, alternating current lasting 1.5 seconds. Defibrillation shocks were applied 10 seconds after the onset of ventricular fibrillation in each episode. In case of defibrillation failure, an internal 40-J "rescue" shock was applied to the heart. Only in the case of defibrillation failure with the 40-J shock, an external 360-J shock was applied.

To ensure stable conditions of the model, the DFT was determined for the 6 ms/4 ms waveform in part I and for the 3 ms/2 ms waveform in part II at the beginning of the otherwise randomized DFT testing protocol and every 2 hours thereafter. If the DFT energy level differed by >=5 J between these testing episodes, the data obtained for that pig were excluded from analysis.

Statistical Analysis
All data are expressed as mean±SD. Overall differences in stored energy at the DFT for the six waveforms in part I and for the seven waveforms in part II were evaluated with ANOVA. When significant differences were present, shock durations were compared with the use of a two-tailed paired t test. Values of P<.05 were considered statistically significant.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Part I
No pig had to be excluded from comparison because of an unstable DFT. The DFT data for each pig and waveform during part I are listed in Table 1Down. The shock strength–phase-1 duration curve is shown in Fig 2Down. Lowest defibrillation energy requirements were observed at a phase-1 duration of 3 ms (22.9±7 J, P<.001, ANOVA). Shocks of shorter phase-1 durations were significantly less successful (1 ms: 36.4±7.5 J, P<.001), as were shocks with a phase-1 duration of 5 ms (30.7±7.3 J, P=.005) and 6 ms (32.9±8.1 J, P=.003). The DFT for shocks with a phase-1 duration of 1 ms differed significantly from the DFT for a phase-1 duration of 2 ms (P=.001). Similarly, the DFT for phase-1 durations of 4 ms was significantly lower than for phase-1 durations of 5 ms (P=.02). There was no significant difference between the shocks with a phase-1 duration of 3 ms, 2 ms (25±6.5 J), or 4 ms (25±7.6 J, P=NS).


View this table:
[in this window]
[in a new window]
 
Table 1. Defibrillation Threshold Values for the Seven Pigs and Six Different Phase-1 Durations in Part I of the Study



View larger version (12K):
[in this window]
[in a new window]
 
Figure 2. Mean defibrillation threshold±SD (ordinate) for the 7 pigs of part I plotted against different phase-1 durations (abscissa). The lowest defibrillation thresholds were observed for a phase-1 duration of 3 ms (P<.001, ANOVA). Probability values given in the figure refer to two-tailed paired t tests for comparison between individual waveforms.

Part II
According to the optimal phase-1 duration determined during part I (based on the lowest DFT), a constant phase-1 duration of 3 ms was chosen for part II. Again, no pig had to be excluded from comparison because of an unstable DFT. DFT values for each pig and waveform in part II are provided in Table 2Down. The phase-2 duration had a significant influence on the stored energy at the DFT (P=.003, ANOVA). This resulted in two significant DFT minima for varying phase-2 duration. One minimum was observed at 2 ms (22.5±4.2 J) and the other at 4 ms (22.5±4.2 J). Both DFTs were significantly lower than with shocks of intermediate phase-2 duration of 3.3 ms (26.7±6.1 J, P=.04 each, Fig 3Down). Shortening of phase-2 duration to 0.7 ms led to a significant increase of the DFT (31.7±9.3 J, P=.03 compared with phase 2=2 ms), as did further prolongation of phase-2 duration to 6 ms (28.3±6.8 J, P=.03 compared with a phase-2 duration of 4 ms).


View this table:
[in this window]
[in a new window]
 
Table 2. Defibrillation Threshold Values for the Six Pigs and Seven Different Phase-2 Durations During Part II of the Study



View larger version (13K):
[in this window]
[in a new window]
 
Figure 3. Mean defibrillation threshold±SD (ordinate) for the 6 pigs of part II plotted against different phase-2 durations (abscissa). Duration of phase-1 was constant at 3 ms. Defibrillation threshold showed two minima, which differed significantly from the neighboring phase-2 durations (P=.003, ANOVA). Probability values given in the figure refer to two-tailed paired t tests for comparison between individual waveforms.

The mean impedance at the leading edge of pulse 1 in part I and part II was 34.2±11.6 {Omega}. Application of a capacitance of 70 µF resulted in a system time constant {tau} of 2.4 ms in this model.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
Internal defibrillation energy requirements can be reduced by using biphasic instead of monophasic waveforms,8 by use of an active can configuration9 or by choosing the optimal electrode polarity.10 11 The current study focuses on the influence of different phase durations on defibrillation energy requirements with a 70-µF capacitance. Our results indicate that for such a capacitance in this animal model with a tripolar lead system, the optimal phase-1 duration was 3 ms, equaling a phase-1 tilt of 60%. Several animal and human studies have compared the defibrillation efficacy of shock waveforms delivered from currently applied 120- to 140-µF capacitances with smaller capacitances: In animal studies a lower DFT in terms of stored and delivered energy could be demonstrated with an 85-µF capacitor compared with a 140-µF capacitor for both monophasic and biphasic shocks with epicardial defibrillation patches.2 5 A dependency of the optimal phase-1 duration on changing electrode impedances has been reported in a clinical study by Swerdlow et al4: By comparing shocks of 65% phase-1 tilt delivered from 60- or 120-µF capacitors, it was found that defibrillation efficacy was higher with smaller capacitances for high-impedance pathways, whereas for low-impedance pathways the opposite was true. The authors concluded that for a constant phase-1 tilt, different capacitances and thereby different phase-1 durations might be optimal for changing electrode impedances. Although in a recent clinical study there was a trend toward lower DFTs in terms of energy for 60-µF capacitors as opposed to 120 µF, this did not reach statistical significance.3 Because most clinically available ICDs apply shock waveforms with a constant phase-1 tilt, all except one3 of the studies cited above used a 65% tilt of the first phase irrespective of the capacitance applied. However, recent studies raised the issue whether different tilts than 65% would render lower DFTs: Two human studies demonstrated an increased defibrillation success with tilts of 42% to 50% compared with tilts of 65% to 80% and a 120-µF capacitance.6 12 In one study the time constant {tau} was calculated to be {approx}8 ms.6 Therefore, pulse 1 tilts of 65% as used in many clinical devices may be too high,6 12 possibly because of refibrillation caused by low-voltage shock tails compared with lower tilts.7 13 However, simple replacement of a phase-1 tilt of 65% by a fixed phase-1 tilt of 42% to 50% may not always be advantageous. On the basis of mathematical models, the optimal phase-1 tilt increases with decreasing time constant {tau} for monophasic as well as for biphasic shocks.14 15 16 We could demonstrate that for a low time constant of 2.4 ms, the optimal phase-1 tilt was 60%. Despite the differences of the models this is higher than the optimal phase-1 tilt for larger capacitances and higher impedances,6 12 thus supporting the concept that the optimal phase-1 tilt is dependent on the time constant. Consequently, studies that compare the defibrillation efficacy of shocks delivered from different capacitances should test each capacitance at its waveform with the optimal tilt. In fact, because the volume of the capacitor is proportional to the maximal stored energy, only a reduction of the DFT by low-capacitance shocks with optimized phase duration compared with shocks from currently available 120- to 150-µF capacitances at optimal phase duration would result in lower capacitor volumes.

Several mechanisms have been suggested to contribute to defibrillation with monophasic shocks such as prolongation of action potential duration and refractory period or resynchronization of the repolarization state of the myocardium.17 18 Beyond that, depolarization of myocardial cells is considered to be an important mechanism.19 Experimentally, a hyperbolic stored voltage–shock duration curve at the DFT has been found for monophasic shocks.20 A similar strength-duration relation has been proposed to sufficiently describe the action of phase-1 of biphasic shocks,15 which is supported by the findings in part I of the present study.

There are conflicting results on the optimal ratio of phase-1/phase-2 duration. In an animal study, Dixon et al21 demonstrated lower energy requirements for ventricular defibrillation with biphasic shocks and a second phase of equal or shorter duration than the first phase. Similarly, Gliner et al22 found lower ventricular defibrillation energy requirements in external defibrillation for a phase-1 duration set at 50% or 60% of the total shock duration. In human atrial fibrillation, Cooper et al23 most recently observed lowest internal atrial defibrillation thresholds for biphasic shocks with a phase-1 duration longer than phase-2 duration. However, in a human study on internal ventricular defibrillation, different tilts of the second phase of the biphasic shock did not significantly affect defibrillation energy requirements.24 By contrast, in an animal study on ventricular defibrillation, lower DFTs for shocks with the second phase longer than the first phase were reported.25 The differences in underlying arrhythmias and models make the comparison between these studies difficult. However, a possible reason for the findings of higher defibrillation success of shocks with phase-2 durations longer than phase-1 duration for lower time constants is provided by Kroll.15 Because the residual charge left on the cell membrane after delivery of phase 1 is thought to cause postshock arrhythmias, thus diminishing defibrillation success, he assumed that the major function of phase 2 was to unload ("burp") this residual membrane charge. Thus according to his mathematical calculation, the optimal phase-2 duration would become longer than phase-1 duration at time constants {tau} shorter than 3 ms as experimentally demonstrated in our study. In the current study, two phase-1/phase-2 duration ratios with minimal defibrillation energy requirements at the DFT were observed, 60%/40% (phase-2 duration: 2 ms) and 43%/57% (phase-2 duration: 4 ms). Similar findings have been described by Feeser et al.26 Using a constant phase-1 duration of 3.5 ms, they found two voltage minima at the DFT for phase-2 durations of 4 ms and 7 ms with significantly higher voltages at the DFT for phase-2 durations between these two values. They suggested two possible mechanisms accounting for these observations: (1) Depolarization after hyperpolarization: The role of the second phase is to depolarize that half of the myocardial cell membrane that has been hyperpolarized during phase 1. The effect that hyperpolarization during phase 1 of the biphasic shock reactivates sodium channels that were partially inactivated because of low resting membrane potentials during ventricular fibrillation27 was originally described by Jones et al.28 They called this "prepulse conditioning." (2) Hyperpolarization after depolarization: Excitation on the side of the cell that has been depolarized during phase 1 may be halted by the now-hyperpolarizing phase 2. Halting of myocardial excitation by a hyperpolarizing impulse after the excitation threshold has been reached was described by Weidmann.29 It was proposed26 that with increasing phase-2 durations first, the mechanism of depolarization after hyperpolarization might be predominating, thus resulting in lower voltages at the DFT. Then, with longer phase-2 durations the effect of hyperpolarization after depolarization may outweigh the beneficial effect of depolarization after hyperpolarization on the other side of the myocardial cells, thus leading to an increase of the voltage at the DFT. Finally, further prolongation of phase-2 duration makes phase 2 behave like a monophasic shock with a second decrease and increase of the voltage at the DFT. These results on phase-2 durations differ from clinically used shock waveforms that include fixed phase-1/phase-2 duration ratios of 60%/40% or 50%/50%. The latter is based on an animal study of Tang et al30 that investigated current strength requirements for a constant phase-1 duration of 3.5 ms and changing phase-2 durations. Lowest current at the DFT was demonstrated for a phase-2 duration of 2 ms. However, two optimal phase-2 durations may have been missed in that study because of the large increments of the phase-2 durations in contrast to the results of Feeser et al (1-ms increments) and our own findings (0.6- to 0.7-ms increments).

Study Limitations
In this porcine animal model with a tripolar lead system including a submuscular patch, the time constant {tau} was short because of the low impedances observed compared with most human ICD implants. However, the finding of more than one optimal phase-2 duration may be extrapolated to other lead configurations and impedances because similar results have been found despite different models.25 26 Although the relative heart weight of the applied pigs, which is 0.3% of the body weight of the animal, is comparable to humans,31 differences of this model due to the lack of organic heart disease and the mode of induction of ventricular fibrillation may have caused differences to spontaneous episodes of ventricular fibrillation in patients.

Conclusions
Similar to monophasic shocks, the shock strength–duration curve of biphasic shocks delivered from 70-µF capacitors demonstrated a single optimum for phase-1 duration at 3 ms, equaling a phase-1 tilt of 60%. In contrast, for an optimized phase-1 duration, two significant minima of defibrillation energy requirements were found for phase-2 duration, thereby supporting the concept that the duration of the two phases is optimized independent of each other. Both may be clinically relevant for future optimization of ICD design and programming.

Received September 15, 1997; revision received November 21, 1997; accepted December 12, 1997.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Nelson RS. The pulse generator. In: Kroll MW, Lehmann MH, eds. Implantable Cardioverter Therapy: The Clinical Engineering Interface. Boston, Mass: Kluwer Academic Publishers; 1996.

2. Leonelli FM, Kroll MW, Brewer JE. Defibrillation thresholds are lower with smaller storage capacitors. PACE Pacing Clin Electrophysiol. 1995;18:1661–1665.[Medline] [Order article via Infotrieve]

3. Bardy GH, Poole JE, Kudenchuk PJ, Dolack GL, Mehra R, DeGroot P, Raitt MH, Jones GK, Johnson G. A prospective randomized comparison in humans of biphasic waveform 60-µF and 120-µF capacitance pulses using a unipolar defibrillation system. Circulation. 1995;91:91–95.[Abstract/Free Full Text]

4. Swerdlow CD, Kass RM, Chen PS, Hwang C, Raissi S. Effect of capacitor size and pathway resistance on defibrillation threshold for implantable defibrillators: Circulation. 1994;90:1840–1846.[Abstract/Free Full Text]

5. Rist K, Tchou PJ, Mowrey K, Kroll MW, Brewer JE. Smaller capacitors improve the biphasic waveform. J Cardiovasc Electrophysiol. 1994;5:771–776.[Medline] [Order article via Infotrieve]

6. Natale A, Sra J, Krum D, Dhala A, Deshpande S, Jazayeri M, Newby K, Wase A, Axtell K, VanHout W, Akhtar M. Relative efficacy of different tilts with biphasic defibrillation in humans. PACE Pacing Clin Electrophysiol. 1996;19:197–206.[Medline] [Order article via Infotrieve]

7. Irnich W. Optimal truncation of defibrillation pulses. PACE Pacing Clin Electrophysiol. 1995;18:1:673–688.[Medline] [Order article via Infotrieve]

8. Bardy GH, Ivey TD, Allen MD, Johnson G, Mehra R, Greene HL. A prospective randomized evaluation of biphasic versus monophasic waveform pulses on defibrillation efficacy in humans. J Am Coll Cardiol. 1989;14:728–733.[Abstract]

9. Bardy GH, Johnson G, Poole JE, Dolack L, Kudenchuk PJ, Kelso D, Mitchell R, Mehra R, Hofer B. A simplified, single-lead unipolar transvenous cardioversion-defibrillation system. Circulation. 1993;88:543–547.[Abstract/Free Full Text]

10. Schauerte P, Stellbrink C, Schöndube F, Löser H, Haltern G, Messmer BJ, Hanrath P. Polarity reversal improves defibrillation efficacy in patients undergoing transvenous cardioverter/defibrillator implantation with biphasic shocks. PACE Pacing Clin Electrophysiol. 1997;20:301–306.[Medline] [Order article via Infotrieve]

11. Stellbrink C, Schauerte P, Löser H, Rosenbaum C, Kuckertz E, Vogel M, Messmer BJ, Hanrath P, Schöndube FA. Influence of polarity reversal on defibrillation success with biphasic shocks and a transvenous/subcutaneous defibrillator system in a porcine animal model. PACE Pacing Clin Electrophysiol. In press.

12. Swartz JF, Fletcher RD, Karasik PE. Optimization of biphasic waveforms for human nonthoracotomy defibrillation. Circulation. 1993;88:2646–2654.[Abstract/Free Full Text]

13. Schuder JC, Stoeckle H, Kekar PY, Gold JH, Chier MT, West JA. Transthoracic ventricular defibrillation in the dog with unidirectional rectangular double pulses. Cardiovasc Res. 1970;4:497.[Abstract/Free Full Text]

14. Kroll MW. A minimal model of the monophasic defibrillation pulse. PACE Pacing Clin Electrophysiol. 1993;16:1:769–777.

15. Kroll MW. A minimal model of the single capacitor biphasic defibrillation waveform. PACE Pacing Clin Electrophysiol. 1994;17:1782–1792.[Medline] [Order article via Infotrieve]

16. Cleland BG. A conceptual basis for defibrillation waveforms. PACE Pacing Clin Electrophysiol. 1996;19:1186–1195.[Medline] [Order article via Infotrieve]

17. Dillon SM. Optical recordings in the rabbit heart show that defibrillation strength shocks prolong the duration of depolarization and the refractory period. Circ Res. 1991;69:842–856.[Abstract/Free Full Text]

18. Dillon SM. Synchronized repolarization after defibrillation shocks: a possible component of the defibrillation process demonstrated by optical recordings in rabbit heart. Circulation. 1992;85:1865–1878.[Abstract/Free Full Text]

19. Zipes DP, Fischer J, King RM, Nicoll A, Jolly WW. Termination of ventricular fibrillation in dogs by depolarizing a critical amount of myocardium. Am J Cardiol. 1975;36:37–44.[Medline] [Order article via Infotrieve]

20. Chapman PD, Wetherbee JN, Vetter JW, Trup P, Souza J. Strength-duration curves of fixed pulse width variable tilt truncated exponential waveforms for nonthoracotomy internal defibrillation in dogs. PACE Pacing Clin Electrophysiol. 1988;11:1045–1050.[Medline] [Order article via Infotrieve]

21. Dixon EG, Tang ASL, Wolf PD, Meador JT, Fine MJ, Calfee RV, Ideker RE. Improved defibrillation thresholds with large contoured epicardial electrodes and biphasic waveforms. Circulation. 1987;76:1176–1184.[Abstract/Free Full Text]

22. Gliner BE, Lyster TE, Dillon SM, Bardy GH. Transthoracic defibrillation of swine with monophasic and biphasic waveforms. Circulation. 1995;92:1634–1643.[Abstract/Free Full Text]

23. Cooper RAS, Johnson EE, Wharton M. Internal atrial defibrillation in humans. Improved efficacy of biphasic waveforms and the importance of phase duration. Circulation. 1997;95:1487–1496.[Abstract/Free Full Text]

24. Tomassoni G, Newby K, Deshpande S, Axtell K, Sra J, Akhtar M, Natale A. Defibrillation efficacy of commercially available biphasic impulses in humans. Circulation. 1997;95:1822–1826.[Abstract/Free Full Text]

25. Yamanouchi Y, Mowrey KA, Nadzam GR, Hills DG, Kroll MW, Brewer JE, Donohoo AM, Wilkoff BL, Tchou PJ. Large change in voltage at phase reversal improve biphasic defibrillation thresholds. Circulation. 1996;94:1768–1773.[Abstract/Free Full Text]

26. Feeser SA, Tang ASL, Kavanagh KM, Rollins DL, Smith WM, Wolf PD, Ideker RE. Strength-duration and probability of success curves for defibrillation with biphasic waveforms. Circulation. 1990;82:2128–2141.[Abstract/Free Full Text]

27. Akiyama T. Intracellular recording of in situ ventricular cells during ventricular fibrillation. Am J Physiol. 1981;140:H465–H471.

28. Jones JL, Jones RE, Balasky G. Improved cardiac cell excitation with symmetrical biphasic defibrillator waveforms. Am J Physiol. 1987;253:H1418–H1424.[Abstract/Free Full Text]

29. Weidmann S. Effect of current flow on the membrane potential of cardiac muscle. J Physiol. 1951;115:227–236.

30. Tang ASL, Yabe S, Wharton JM, Dolker M, Smith WM, Ideker RE. Ventricular defibrillation suing biphasic waveforms: the importance of phasic duration. J Am Coll Cardiol. 1989;13:207–214.[Abstract]

31. Rühl B. Gewichte, Faserdicken und Kernzahlen des Herzmuskels und deren Beziehung zu Körpergewicht und Skelettmuskelmasse bei 205 Tage alten, 5 Rassen zugehörigen Schweinen. Zbl Vet Med. 1971;a18:151–173.




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
Y. Zhang, R. S. Ramabadran, K. A. Boddicker, I. Bawaney, L. R. Davies, M. B. Zimmerman, S. Wuthrich, J. L. Jones, and R. E. Kerber
Triphasic waveforms are superior to biphasic waveforms for transthoracic defibrillation: Experimental studies
J. Am. Coll. Cardiol., August 6, 2003; 42(3): 568 - 575.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
K. A. Mowrey, Y. Cheng, P. J. Tchou, and I. R. Efimov
Kinetics of defibrillation shock-induced response: design implications for the optimal defibrillation waveform
Europace, January 1, 2002; 4(1): 27 - 39.
[Full Text] [PDF]


Home page
CirculationHome page
S. R. Shorofsky and M. R. Gold
Effect of Second-Phase Duration on the Strength-Duration Relation for Human Transvenous Defibrillation
Circulation, October 31, 2000; 102(18): 2239 - 2242.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. N. Schauerte, K. Ziegert, M. Waldmann, F. A. Schondube, F. Birkenhauer, K. Mischke, M. Grossmann, P. Hanrath, and C. Stellbrink
Effect of Biphasic Shock Duration on Defibrillation Threshold With Different Electrode Configurations and Phase 2 Capacitances : Prediction by Upper-Limit-of-Vulnerability Determination
Circulation, March 23, 1999; 99(11): 1516 - 1522.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schauerte, P.
Right arrow Articles by Stellbrink, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schauerte, P.
Right arrow Articles by Stellbrink, C.